BASF to develop a high purity poloxamer for Mast Therapeutics
BASF and Mast Therapeutics have agreed to collaborate in the development of a higher purity poloxamer 188. Currently, excipient-grade poloxamer 188 NF, marketed by BASF under the Kolliphor® P188 brand, is a polymer used in a variety of pharmaceutical and biological applications. October 13, 2015